They may also advise you to limit alcohol consumption during your treatment, even on days you don’t receive a dose of Spravato. Consuming alcohol on days you receive Spravato can raise your risk ...

Cybin (CYBN) stock earns Guggenheim's Buy rating with a $35 target, as the firm cites blockbuster potential for CYB003 in line with J&J's (JNJ) Spravato. Read more here.

because you have to dose, monitor, make a decision, redose, monitor, etc. We wanted something, and we're really targeting things that are just like Spravato. You go in, you get those single ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

Tesla boss Elon Musk seems to be on a mission to conquer the world, and even Mars. But his odd-hour rants, alleged Nazi ...

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

Firstly, a patient is required to have treatment-resistant depression and have failed multiple antidepressants to get approval for Spravato. Secondly, there are only two doses of Spravato ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Spravato (esketamine ... not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode. It is estimated that approximately ...